1979
DOI: 10.1021/jm00190a013
|View full text |Cite
|
Sign up to set email alerts
|

Biological properties of transition-metal organometallic compounds. 3. .beta.-Ferrocenylalanine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
14
0

Year Published

1979
1979
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(14 citation statements)
references
References 13 publications
0
14
0
Order By: Relevance
“…Recently, ferrocene and its derivatives have been attracted much more attention in the biological activities [2,3]. Incorporation of a ferrocene fragment into a molecule of an organic compound often obtained unexpected biological activity, which is rationalized as being due to their different membrane permeation properties and anomalous metabolism [4]. Furthermore, the stability and non-toxicity of the ferrocenyl moiety is of particular interest rendering such drugs compatible with other treatment [5][6][7].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, ferrocene and its derivatives have been attracted much more attention in the biological activities [2,3]. Incorporation of a ferrocene fragment into a molecule of an organic compound often obtained unexpected biological activity, which is rationalized as being due to their different membrane permeation properties and anomalous metabolism [4]. Furthermore, the stability and non-toxicity of the ferrocenyl moiety is of particular interest rendering such drugs compatible with other treatment [5][6][7].…”
Section: Introductionmentioning
confidence: 99%
“…Although much work has been directed toward the design and synthesis of fused-pyrazole derivatives [16][17][18][19][20][21], a search of the literatures revealed very few reports concerning pyrazolo-pyrazinones [22]. In the previous papers, we synthesized a series of novel pyrazole derivatives including ethyl 1-(2 0 -hydroxy-3 0 -aroxypropyl)-3-aryl-1H-pyrazole-5-carboxylate derivatives [23], 6-(aroxymethyl)-2-aryl-6,7-dihydropyrazolo [5,1- c] [1,4]oxazin-4-one derivatives [24], ethyl 1-arylmethyl-3-aryl-1H-pyrazole-5-carboxylate derivatives [25], 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives [26] and 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives [27]. The evaluation of biological activity showed that these compounds can inhibit A549 lung cancer cell growth.…”
Section: Introductionmentioning
confidence: 99%
“…Ferrocene derivatives containing heterocyclic systems have attracted special attention in recent years [2][3][4][5][6][7] because of their organic and inorganic properties, as well as for their applications in various areas including components of molecular wires [8], anion sensors [9] and potential organic ferromagnets [10]. Compared with the classical heterocyclic compounds, incorporation of a ferrocene fragment into heterocycles often obtained unexpected biological activity [11]. Furthermore, ferrocene has been studied extensively as it is thought to be responsible for a variety of biological stability and non-toxicity rendering such drugs compatible with other treatment [12][13][14].…”
Section: Introductionmentioning
confidence: 99%
“…20 Compounds in which the cis-Pt(II) and ferrocenyl moieties are combined may also be expected to exhibit biological activity. 21 Thus, (dppf)PtCl 2 , [(dppf)Pt(m-Cl)] 2 2 , [(dppf)Pt (m-OH)] 2 2 and [(dppf)Pt(DMF) 2 ] 2 [DPPF = 1,1bis(diphenylphosphinoferrocene); DMF = dimethylformamide; lower-case abbreviations are used for legends in complexes (i.e. dppf, dmf)] have been shown to exhibit cytostatic activity in vitro against the KB cell line.…”
Section: Introductionmentioning
confidence: 99%